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ABSTRACT
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease with potential to
interfere with breathing ability. It is the third leading cause of 30-day readmission and death in
the US, and the leading cause of mortality and morbidity worldwide. It constitutes a society
burden and poor disease management leads to major health consequences such as acute COPD
exacerbation resulting in frequent costly readmissions, add to its massive direct healthcare costs.
Over $50 billion are spent annually in direct care alone in addition to $15 billion in hospital
readmissions; with 12 million adults are being affected in the United States as of 2018. This
amount in direct cost is likely to increase in the future because of co-morbid diseases, and
numerous indirect costs such as absenteeism. The Centers for Medicare and Medicaid Services
(CMS) as a result initiated the hospital readmission reduction program (HRRP) by imposing
financial penalties on hospitals with excess readmission rates to press them on finding effective
strategies to improve this population’s care quality to reduce readmissions rates affecting
healthcare expenditures. Evidence-based research demonstrates that intervention programs can
reduce readmission, especially those who deploy an interdisciplinary team approach, with
various care interventions that were successful at enhancing the quality of healthcare. Several
intervention programs had a varying success rate as depicted by different studies. This
integrative review aimed at researching intervention programs supporting reduction of hospital
readmissions in patients with a COPD diagnosis.
Keywords: COPD, chronic obstructive pulmonary disease, readmission, rehospitalization, reduction, decrease, lowering, prevention.
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SECTION ONE: FORMULATING THE REVIEW QUESTION
It is in all patients’ expectations when entering a healthcare facility for any health
complaint to receive optimal patient-centered care to effectively control their symptoms with
minimal side effects from treatments. This type of care is highly valued and encouraged by all
healthcare organizations promoting quality improvement (QI) in the healthcare continuum since
it is being supported by well documented evidence in the literature among major contributing
factors to best health outcomes and patient satisfaction. Despite these beneficial impacts with
patient satisfaction known among key quality performance measures hospitals so desperately
need, COPD patients’ discharge care coordination planning seems to be lacking (Alshabanat et
al., 2017), resulting in poor health and increasing risk for hospital readmissions.
COPD affects 12 million adults in the United States estimated at almost $50 billion in
direct cost annually. Acute COPD exacerbation (AECOPD) is responsible for up to 70% of all
COPD healthcare cost with $15 billion per year in readmissions alone (Press et al., 2018). The
following year, nearly 6.4% of Americans are reported to be diagnosed, which number is
believed to be underestimated due to more than 50% adults with low pulmonary function
reported being unaware they had COPD. The prevalence of COPD is expected to increase in the
next 30 years because of the aging population (Mcgurran et al., 2019). Although not curable, it is
a manageable disease with potential to become debilitating if left untreated with increase in risk
for morbidity and mortality. COPD is the leading cause of morbidity and mortality worldwide
and the third leading cause of both hospital readmission and death in the United States
(Alshabanat et al., 2017; Press et al., 2018). Resulting excess health consequences from acute
exacerbations (AECOPD) represent a major public health concern and high degree of burden on
patients, their families, and society. Its direct economic cost is already alarming in addition to
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high readmission rates causing healthcare costs to rise significantly. This was concerning enough
for the Centers for Medicare and Medicaid Services (CMS) to make it part of their Hospital
Readmission Reduction Program (HRRP) designed to financially penalize hospitals with excess
readmissions. Such imposed financial pressure left those hospitals with no choice other than
change their course on ways they provide care to this patient population by finding new
strategies through programs or interventions designed to improve their quality care and reduce
their readmission risks for them to remain well and stable in their respective communities. Those
financial and health data are frightening and must be concerning to all healthcare professionals
who are becoming aware of them to find best strategies through evidence-based research for best
clinical care practices to improve this population health. Inpatient COPD management is
documented to have significant care gaps particularly with discharge planning and appropriate
maintenance treatment in the community for these patients (Alshabanat et al., 2017). There was
lack of follow up within the community and poor adherence with regard to prescribed
medications (Alshabanat et al., 2017). These are troubling evidences triggering high degree of
curiosity to conduct this integrative review (IR) with objective to find effective intervention
programs addressing readmission risk factors to reduce this population readmission rates.
Defining Concepts and Variables
Concepts and variables are important in literature reviews because of the role they play in
conducting the study. It is important to minimize any ambiguity in the IR by clearly describing
what is meant by the variables and how they will be used in the review (Toronto & Remington,
2020). For this reason, concepts and variables for this study were being identified and well
defined by the project leader prior to even start the review. They lead the researcher’s focus of
what they have already known of the problem and what they are looking to accomplish in their
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project. Additionally, they assist readers in having a broader understanding of what the research
is about. The identified concept for this integrative review is any tailored intervention program,
pharmacologic or non-pharmacologic designed to decrease potential risk factors to the problem
of interests such as COPD readmissions, mortality, morbidity rates, and healthcare costs. The
intervention program can be operationalized to be measured through the use of indicators
including increase in self-care management, patient engagement, improve discharge care
coordination, health outcomes, medications adherence and patient satisfaction. The identified
variables are the problem of interests being manipulated by the concept or the intervention
program. In other words, identified intervention also known as concept has full potential to
influence the variables which can be easily measured for level of success achieved through
reduction of readmission, mortality and morbidity rates, and decrease healthcare costs for quality
improvement.
Rationale for Conducting the Review
The serious health and financial threats this condition poses on this patient population
and the society are highly concerning. Previously documented evidence-based research on this
paper has demonstrated COPD causes serious health and financial consequences from frequent
and/or severe COPD complications such as AECOPD resulting in costly subsequent
readmissions. AECOPD related-hospitalizations account for the highest portion of the economic
costs for this disease (Alshabanat et al, 2017, p. 961). Early readmission following a
hospitalization for AECOPD remains an important clinical problem (Adamson et al., 2016).
These should not be continued norms for this population since the condition is manageable.
Substantial efforts should be made by DNP prepared nurses, the leaders in the field to reduce
potential factors associated to recurrent AECOPD known as main factor in COPD readmissions
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to improve patients’ clinical outcomes and reduce the societal burden. For these reasons, it is
worth conducting this review to find best evidence effective in reducing readmission rates in
COPD patients to be implemented in clinical care practice for quality improvement. Intervention
strategies to reduce readmissions may need to expand beyond COPD specific treatments alone
but also should include improvements in patients’ education, behavior modification through
health coaching, and facilitation of prompt access to outpatient health care expertise when
needed to impact overall health and quality (Press et al., 2018).
Purpose and/or Review Question(s)
Quality of care delivered to patients with COPD is known to be lacking across the care
continuum, and may contribute to high rates of readmissions (Press et al., 2018). The authors
further said readmissions may be the proxy for other important health factors or outcomes,
including quality of life, social determinants of health, adherence deficit, or multi-morbidity.
This project aimed at determining the best intervention support programs offering services to
eliminate or reduce pertinent care gaps interfering with transitional discharge quality, increased
disease knowledge, treatment adherence, early discharge follow up and management of COPD
exacerbations primarily for reduction of readmission or re-hospitalization rates in COPD patients
with excess readmissions rates.
The Institute of Medicine (IOM) (2005) has a straightforward definition of patient safety:
“the prevention of harm to patients (p. 1011).” Since readmissions are costly and many are
believed to be preventable, there have been recent federal efforts targeting reductions. In 2014
the Center for Medicare and Medicaid Services (CMS) initiated the Hospitals Readmissions
Reduction program (HRRP) changing the financial incentives for COPD care for hospitals with
more readmissions than expected, within 30 days of index AECOPD hospitalizations (Press et
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al., 2018). This indicated more should be done to improve this population quality care, reduce
readmission rates to prevent those financial penalties. This as a result, leading the project leader
to this clinical question:
“In patients with a diagnosis of Chronic Obstructive Pulmonary Disease, what
interventions support the reduction of hospital readmissions?”
The question was better approached as goals were established to be followed
methodically by the project leader for best result outcomes. First, through review of clinical
research, the project leader has identified if there were existing evidence base intervention
programs effective to significantly reduce COPD readmission or re-hospitalization rates.
Moreover, the project leader assessed the findings to evaluate its worth to be replicated in future
healthcare organizations or clinical practices experiencing excess readmissions within this
population for QI.
Second, the leader assessed if study results would be worth disseminating and
implementing in the near future at a healthcare organization for concrete assessment of its level
of success. The leader examined this can be done through the use of the Plan-Do-Study-Act
(PDSA) cycle and Hospital Consumer Assessment of Healthcare Providers and Systems
(HCAPS) for identification of area of strengths and weaknesses for continuous quality
improvement (CQI).
The leader analyzed these goals can be achieved through the development of a well
structured plan containing fundamental elements pertinent to the process of a successful project
completion. This plan was comprised of Whittemore & Knafl framework, a comprehensive
description of eligibility criteria for selection of articles focusing on the problem question, and
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the process of search strategies including keywords to search databases for best available
evidence addressing the problem topic followed by method of appraisal
COPD readmission or re-hospitalization is the phenomenon of interest. While it appears
to be focused, in reality when it is analyzed in its proper context, it is found to be broader. The
associated readmission factors are numerous and any of them being considered within a research
study will generate overwhelming information.
It is imperative clear knowledge and understanding are established to best approach this
topic. A comprehensive search of the literature is a practical strategy to move toward that path
followed by critique and analysis of retrieved articles for selection of latest relevant clinical
evidence addressing the problem question for result findings to be worth implementing in future
healthcare organizations experiencing similar issue.
Formulate Inclusion and Exclusion Criteria
There is no greater driver to this integrative review than the problem question: “In patients
with a diagnosis of Chronic Obstructive Pulmonary Disease, what interventions support the
reduction of hospital readmissions?” The topic had become a priority after thoughtful
consideration following a systematic search revealing grave consequences associated with this
population and the high demands for effective intervention programs addressing related risk
factors for patients’ well-being and the need to contain healthcare costs. To thoroughly answer
this question, a comprehensive systematic search was inevitable but not before standard for
search inclusion and exclusion criteria was formally and clearly developed. Establishing
inclusion and exclusion criteria for study participants is standard, required practice when
designing high quality research protocol (Patino & Ferreira, 2018). With designing this study, it
was very important the inclusion and exclusion criteria were well and carefully defined,
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considering the major impact they have on research outcomes in relationship to the search
question for validity and accuracy. Per Patino and Ferreira (2018), inclusion criteria are key
features of the target population that will be used by the project leader to address the research
problem. In contrast, exclusion criteria are key features of potential study participants who meet
inclusion criteria but present additional traits that could interfere with best study outcomes
(Patino & Ferreira, 2018).
Inclusion criteria for conducting this integrative review took into account a series of
methodological issues specific to COPD readmissions research. Included articles should be peerreviewed from worldwide, written in English language, males or females adults diagnosed with
COPD, published within 10 years span from 2010 to 2020; and involved intervention services for
COPD readmissions reduction. The excluded articles were those non research articles (editorials,
commentaries), written in foreign language, older than 10 years span, non adults without a
COPD diagnosis, and articles with interventions not pertaining to COPD readmission reduction.
This, also represented in table 1 below allowed a well planned method to search the literature for
collection of most relevant articles for the review.
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Table 1
Inclusion and Exclusion Criteria
Inclusion

Exclusion

Peer-reviewed articles from worldwide

Non research articles
(editorials, commentaries, Abstract only
articles)

English language
Published within 10 years span from 2010
to 2020

Written in foreign language
Older than 10 years span

Has a COPD diagnosis

Do not have a COPD diagnosis

Adults males or females of all age

Non adults

Involved COPD readmissions and
intervention services for reduction

Intervention not pertaining to COPD
readmission reduction

Conceptual Framework
A well structured research is built on a framework, necessary to guide its path and
enhance its credibility. There are the theoretical and the conceptual frameworks. The project
leader should have profound knowledge and understanding of them to validate which one is best
suited for this research project to be constructed on, for optimal results. The purpose of the two
frameworks is to make research findings more meaningful, acceptable to the theoretical construct
in the research field and ensures generalizability (Adom, Hussein & Agyem, 2018). A conceptual
framework, Whittemore and Knafl’s 2005 updated methodology was found to be the most
suitable to guide this integrative review.
The topic problem is a deeply concerning subject. It is of great importance and should be
addressed promptly and effectively through a systematic review of the literature to lessen the
associated heightened consequences. Its research should be expanded beyond regular review
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method to one which includes diverse approaches such as the integrative review (IR), facilitating
access a wide range of clinical evidences to enhance the understanding of the research problem.
The integrative review is described as the only method that allows for the combination of diverse
methodologies (i.e., experimental and non-experimental research) and has the potential to play a
greater role in evidence-base practice for nursing (Whittemore & Knafl, 2005, p. 547).
According to Broome (1993), integrative review is a specific review method that summarizes
past empirical or theoretical literature to provide a more comprehensive understanding of a
particular phenomenon or healthcare problem (Whittemore & Knafl, 2005, p. 546). Despite these
benefits of integrative study, the management of combined diverse methodologies is complex
and can contribute to lack of rigour, inaccuracy and bias (Beck, 1999; O’Mathuna, 2000, as cited
in Whittemore & Knafl, 2005).
These potential consequences can be prevented to increase study credibility through the
use of the updated Whittemore and Knafl’s framework derived from Cooper’s (1998) aligned
with systematic review or meta-analysis method. Referring to Cooper’s framework, issues
specific to integrative study and challenges of organizing various data sources have not been
addressed. Thus, this framework will be updated to meet IR criteria (Whittemore & Knafl, 2005).
As a result, this integrative review analysis was guided by the five steps of the updated
framework which include problem identification, literature search, data evaluation, data analysis
(data reduction, data display, data comparison, conclusion and drawing) and presentation to
understand the problem question in a broader perspective. This framework allowed systematic
and rigorous review and synthesis of the literature.
The first step of the integrative review was begun with clearly identifying the problem
question to be addressed and the related concepts facilitating data reduction from the primary
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sources as well as motive behind conducting the review. The literature search stage was focused
on key areas pertinent to find relevant sources for the review including the search terms, the
different accredited databases, and the inclusion and exclusion criteria. The evaluation and
interpretation phase was done at the project leader’s best judgment while leveling of the articles
for best evidence was done through use of Melnyk hierarchy table known to be effective for
grading in research study particularly where diverse primary sources are involved as in this
integrative review. A level of evidence pyramid places evidence into different hierarchical
categories based upon the strength of the evidence to answer clinical practice questions from
strongest to weakest evidence (Melnyk, 2016). The process of data analysis presents data from
the primary sources into one well synthesized conclusion, and the presentation phase which can
be summarized through different strategies including a graph or table.
SECTION TWO: COMPREHENSIVE AND SYSTEMATIC SEARCH
Search Organization and Reporting Strategies
When conducting a review, methods have to be established and followed to ensure its
validity. It was ensured that all criteria pertinent to the process were met including the use of
Whittemoore & Knafl updated methodology to properly guide the project, its approval from the
Institutional Review Board (IRB), and the completion of Collaborative Institutional Training
Initiative (CITI). The problem question is to be answered with the most recent and relevant
articles. Therefore, the use of proper databases such as CINHAL, Health Source, MEDLINE and
PubMed; appropriate limiters, search techniques, and terms were made priority by the project
leader in charge of collecting the articles from the literature.
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COPD readmissions are known to cause a major health and financial burden. This is so
concerning that the Center for Medicare and Medicaid Services (CMS) initiate the HRRP for
hospitals to find best strategies to reduce readmission rates. Certainly, the gravity of this
persistent issue among this population did not go unnoticed in the research world. For decades
attempts have been made in search for solutions and, an overwhelming amount of published
articles seeking for potential effective interventions, risks factors and implications are being
made available through the literature. Within the search strategy process, there was no hand
searching. A systematic search of published papers within the past ten years was carried out from
four electronic databases: CINAHL, Health Source, MEDLINE full text, and Pubmed. For
accuracy of the search, the project leader has sought the university librarian assistance for
identification of accredited databases, best search techniques and key terms to search articles
corresponding to the phenomenon of interest from the latest literature available. The topic
question had to be modified by the project’s chair suggestion to make it broader and for chosen
key searched terms to be specific to generate as many relevant articles. Within the problem
question, “COPD 30 day readmissions” was replaced by “COPD readmissions” to be more
general. Several search terms were depicted from the problem question to form key terms
combination as follow (COPD or Chronic obstructive pulmonary disease) and (readmission or
re-hospitalization) and (reduction or decrease or lowering or prevention) which were replaced
from (Chronic obstructive pulmonary disease) and (30 readmission rates) and (community
intervention programs) for generating unsatisfied results. Within the search process, very few
limiters were used to enhance access to as many relevant articles possible. The first set of
keywords was used on each database, limited to English language and within five to 10 years
span. 1037 articles combined were obtained with (177) from CINHAL, (40) from Health Source,
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(250) from MEDLINE full text, and (570) from PubMed respectively. The search was
determined as saturated when many of the same articles kept on reappearing with new searches
or modifications within the searched terms. These collected articles were later reviewed for
selection of the most relevant ones to conduct the study. Screening in study selection process is
an essential step which involves reviewing the citations resulting from a search and selecting
those deemed relevant for full text retrieval, and critical appraisal of the retrieved studies
(Toronto & Remington, 2020). Although peer review articles were not among the set limiters,
however, they were largely used for the review with exception of one report. The selection
process was taking place, taking into account defined set of inclusion and exclusion criteria or
eligibility criteria as previously defined.
Terminology
Because of its importance in research, terminology should be described accurately to
avoid all potential confusion. The project leader should be ascertained terms used in her narrative
reflect exactly what they are meant to be based on their respective field of research. The terms
including database, search engine, platform and interface are generally used in research and in
many cases some make the mistake by using them interchangeably. Having a clear understanding
of their individual meaning was a wise step to take by the project leader prior to approach the
study. The ability to differentiate them from each other helped greatly when they had to be used
in the process, keeping in mind what they meant to be referred to, and those who may be
interested in replicating the search based on documented information. Any misinterpretation of
those terms or using them interchangeably may influence the study credibility and validity, and
has the potential to mislead readers following written instructions within the project in attempt to
replicate the search for quality improvement. For the purpose of this project, the term “database”
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was used across the process not by choice but rather due to its appropriateness considering it was
meant to be used for searching articles to be selected for the study. The articles were searched
electronically through different databases from Jerry Falwell Library of Liberty University with
each database indexes’ diverse resources along with information pertinent to them such as titles,
publishers, and dates among others.
SECTION THREE: MANAGING THE COLLECTED DATA
The selected studies were recent, and appropriate for the conduction of this integrative
study objective to find intervention supporting reduction of COPD readmission rates. They were
prioritized following a robust review protocol of the collected literature which includes the use of
a literature matrix to review, critique and analyze them thoroughly with focus strictly on set
eligibility criteria, rigor and relevance for inclusion determination.
The collection management strategy was based on the three steps recommended guideline
by Toronto and Remington (2020) who noted when sorting the collected citations, there are three
processes: screening by relevance, then selecting by full text, and finally sorting into studies.
First, the retrieved combined 1037 articles were saved, which titles were examined for duplicates
and clearly irrelevant studies for exclusion totaled at 380. This step was followed by screening
abstracts of the remaining 657 articles found to be doubtful for relevance based on their titles or
difficulty to determine relevance from the title alone. At this stage, two factors were considered
for inclusion and exclusion. It was divided into two categories including: 1) the record of
excluded irrelevant abstracts (566) and 2) those with citations determined to be relevant (91)
considered for full text review. As those potential relevant articles were identified, their full text
versions were obtained for deeper screening. At this step in the process, numerous articles were
found to be relevant to the search problem from which twenty (20) were selected as the most

24

REDUCING COPD READMISSION RATES

relevant per the inclusion criteria and their level of evidence. In the selection process, included
articles from the included full text articles record category were those at the highest level in
Melnyk table of evidence. The use of the Melnyk hierarchy table has lead in sorting most
relevant articles to the research problem to conduct the review to increase its finding validity,
and reliability. Of the 20 articles selected, there were 3 level Is (systematic review), 16 level IIs
(randomized control trials), and one level VII (report). The remaining 71 were excluded in part
either for possible bias including addressing readmissions caused by combined AECOPD and
other comorbidities, or intervention not prioritizing reducing COPD readmissions, or for being at
the lowest level in the hierarchy table of evidence despite they were found to be relevant to the
phenomenon of interest. This process is represented below using the PRISMA Flow Chart
(Moher et al, 2009).
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Figure 1
Literature PRISMA Flow Chart
Additional records
identified through other
sources
(n =0)

Recordsidentify
identified
through
Records
through
database
searching
database
searching
CINHAL(177)
Health Source (40)
Medline (250)
Pubmed (570)
(n =1037)

Records after duplicates and clearly
irrelevant articles removed
(n=657)
Records abstracts screened
(n =657)

Records of included
abstracts for full text
assessment for eligibility
(n=91)

Records excluded
irrelevant abstracts
(n =566)
Full text articles excluded
(n =71)

Studies included in the
integrative studies (n= 20)
Note: PRISMA Flow Chart representing process of data management
Moher, D., Liberati, A., Tetzlaff, J., Altman, G. D. The PRISMA Group (2009). Preferred
Reporting Items for Items for Systematic Reviews and Meta-analyses: The PRISMA Statement.
PLoS Med 6(6): e1000097. https://doi.org/10.1371/journal.pmed.1000097
SECTION FOUR: QUALITY APPRAISAL
Sources of Bias
All studies including integrative review are susceptible to biases that must be rigorously
planned and/or accounted for by researchers (Almeida & Goulard, 2017). Per them, bias is
defined as any and all distortions during the investigation process, which can occur in any type
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of design. However, some are susceptible to systematic reviews classified in three categories
including: selection bias, information bias, and confounding bias (Almeida & Goulard, 2017). It
is well documented bias results from systematic altercation from the truth. Although we do not
know the exact truth, different conclusions lead readers to believe that alternate inclusion and
exclusion criteria result in biased conclusions (McDonagh et al., 2013). False result outcomes
may result in major consequences from implementation of under or overestimate guidelines
and/or interventions findings influencing clinical treatments. Efforts were made for these
potential consequences to be at least limited as complete elimination of risk for bias in research
is unrealistic.
In integrative review where evidence from varied studies is combined, considering the
risk for bias in individual studies is imperative or results may be influenced. Therefore, in
conducting this review it was ensured its methodological rigor was maintained by taking crucial
steps to minimize all potential risk for bias by defining the project study, using appropriate
methods and framework, and developing set of inclusion/exclusion criteria to influence its result.
Methods used should be adequate to prevent bias from occurring, and it is vital studies included
in the review have comparable methodological quality and the necessary information to allow
the identification of selection, gauging, and confounding biases were avoided (Almeida &
Goulard, 2017, p. 554). In the process of articles collection, it was ensured every article retained
for full text review was thoroughly evaluated for methodological strengths and weaknesses prior
to make final selection of those in direct relationship with the problem question to enhance study
rigor. As per Whittemore and Knafl (2005), reviewers retain the responsibility to make
judgments about the methodological strengths and weaknesses of included studies prior drawing
conclusion about the phenomenon of interest (Jackson, 1980), in order to achieve rigor in the IR.
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Internal Validity
By combining the evidence from several studies, it is important to consider the risk of
bias in each study. If study methods are not adequate, results from observational studies may be
biased (Almeida & Goulard, 2017). Knowing what is known; all susceptible biases were
rigorously planned and/or accounted for by the project leader. Study validity was enhanced
through the use of strategies to avoid all potential sources of all types of bias such as selection,
information or confounding, while the wide range of factors influencing validity and reliability
were reinforced at every step in the research process. Close attention was paid to these key
factors within the studies including authors’ affiliations, researcher’s own bias, objectivity and
honesty, sample selection, sample size, design of research tools, and statistical analysis of the
data. Bias may exclusively impact study results to be completely inaccurate or far from the truth.
Throughout the process strong measures were taken to limit factors capable of contributing to
any unfortunate circumstance of bias by ensuring the quality, methodological strengths and
weaknesses of included studies prior drawing conclusion about COPD readmissions reduction to
strengthen review validity. Collected studies were thoroughly examined by the project leader for
bias prior making it to the inclusion list. Sets of inclusion and exclusion criteria were clearly
defined to prevent ambiguity. One of the primary focuses of developing inclusion criteria is to
minimize ambiguity. Greater ambiguity in inclusion criteria increases the possibilities of poor
reproducibility due to many subjective decisions regarding what to include, potentially resulting
in at least random error in study selection (McDonagh, et al., 2013).
Appraisal Tools
Providers are expected to provide patients with the highest quality care based on the best
existing evidence research. As we anticipate this review finding is likely be used for that
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purpose, to meet that threshold we critically appraised all included articles to carefully assess
their levels of validity, reliability, quality, value, and relevance for best results to influence
healthcare professionals’ clinical decision in clinical care practice to improve healthcare
outcomes. It is essential to combat information overload, identify papers that are critically
relevant and continuing professional development (Al-Jundi & Sakka, 2017). Critical steps to
appraise those articles involved primarily the assessment of research methods used for every
individual study through the use of checklists specific to the study design. Standard set of
common questions in relationship to the phenomenon of interest, study design, selection issues,
outcomes and how they are measures among others were completed followed by review of main
study sections such as (1) study overview (author (s) and their affiliation(s), articles title, key
objective, publishing journal and the year and potential conflict of interest); (2) abstract which
summarizes clear details of the study such as a clear written study aim, the study design,
demographic data, type of groups, type of interventions and measuring tools;(3) introduction in
which is presented a clear picture of previous work addressing the problem, their limitations and
why is this review is necessary; (4) methods outline details of how the study was carried out, (5)
results reveal what actually occur and (6) discussion describing an absolute comparison of
current findings with what have already known. This process ensures included articles are
relevant for this study credibility (Al-Jundi & Sakka, 2017).
In the appraisal process of the final selection of those included articles, the Melnyk table
of evidence was used for leveling them to ensure those with the highest level of evidence were
prioritized to enhance rigor of research finding. The use of this tool has contributed in sorting the
relevant articles with the highest level of evidence. Petrisor and Bhandari (2007) judged it is
necessary to place the available literature into a hierarchy as this allows a clearer communication

29

REDUCING COPD READMISSION RATES

when discussing studies, both in day-to-day activities such as teaching rounds or discussions
with colleagues, but especially when conducting a systematic review so as to establish a
recommendation to practice. The avoidance of bias is one more benefit offered by using the
hierarchy table of evidence necessary to enhance study rigor. The understanding behind placing
studies into a hierarchy is that those in the highest position are considered as “best evidence.” In
the case of therapeutic trials this is known as randomize controlled trial (RTC) and meta-analyses
of RTCs. RTCs have an ability to help control bias. Bias which exists in many forms can
interfere with a study outcome in ways that may over or underestimate what the true treatment
effect is (Petrisor & Bhandari, 2007).
This literature matrix contained pertinent information of reviewed selected studies
highlighting among them diverse intervention strategies that have been tested within different
healthcare settings to be evaluated for effectiveness in reducing COPD readmissions. This tool
not only strengthens quality and relevance of the review, increases confidence if results should
be replicated in clinical settings for best practice, but as well will influence healthcare
professionals’ decisions making in clinical practice and in creating policies that define and
integrate appropriate standards addressing COPD population health care needs and conditions for
that level care to occur to reduce readmissions.
Applicability of Results
In research study, taking into account strengths and weaknesses of designs, sampling,
results, and discussion among others are critical to ensure its validity and reliability but yet not
enough for a study to be categorized as useful. Regardless of the level of strengths and
weaknesses, one important factor that can affect this IR usefulness is the applicability of results
to broader population or situations. The broader the study results are applicable to different
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population or situations; the stronger is its generazability level. This is one more important tasks
the project leader had made priority to enhance study usefulness. Generazability is important to
measure of how useful the results of this IR are for larger group of COPD patient population or
others and/or situations. It is anticipated results of this IR will have good generazability due to
the fact they are applicable to a wide range of chronic illnesses apart from COPD population
with excess readmissions. They include chronic heart failure (CHF), diabetes mellitus (DM),
pneumonia and other chronic lungs diseases, not limited to decrease in costs of healthcare. In the
process of reviewing the selected articles, some key considerations have been made to analyze
them for applicability. Close attention was paid on whom and what from the study group were
included and excluded, in addition to the details and timing of every intervention. Knowledge
obtained was used to balance if the characteristics of the group studied are similar to specifics of
COPD patients with increased readmissions and beyond, which as a result will increase
confidence for review finding to be replicated in future clinical practice.
Reporting Guidelines (Whittemore &Knafl)

Systematic bias and error can occur at any stage of the review (Oxman, 1994; Dunkin,
1996, as cited in Whittemore & Knafl, 2005 p. 548).When conducting research; all measures
should be in place to avoid all potential deficiencies in the reporting process. In the absence of
this standard, avoidable errors capable to negatively influence study findings are likely to occur.
As a result, all efforts were made for this to be prevented. This study is guided by Whittemore
and Knafl (2005) updated methodology to make finding more meaningful, acceptable to enhance
its validity and credibility. A research study without a guideline will lack appropriate direction,
increases potential for deviation in the study and ultimately interferes with study end results.
Growing evidence demonstrates widespread deficiencies in the reporting of health research

31

REDUCING COPD READMISSION RATES

studies. Problematic issues include (but are not limited to): non reporting or delayed reporting of
whole studies; omission of crucial information in the description of research methods and
interventions; selective reporting of only some outcomes; inadequate reporting of harms;
presenting data and graphs in confusing and misleading ways; and omissions from or
misinterpretation of results in abstracts (Simera et al., 2010, p. 35). The absence of important
primary sources is subject to make the literature search stage incomplete, increases potential for
error to occur in extracting and interpreting data from the primary sources. Most particularly,
data analysis may be incomplete or lack of an accurate synthesis of data from primary sources.
Analyzing and synthesizing varied primary sources is a challenging process in integrative
review. Therefore, developing data analysis strategies in the updated methodology is a priority
(Whittemore & Knafl, 2005, p. 548).
According to the literature, adherence to the guidelines that provide structured advice on
how to report research studies can lead to dramatic improvement. It can decrease honest errors
and omissions in scientific reports, and improve the accuracy and transparency of publications
which will allow reliable appraisal of presented research (Simera et al., 2010). This was the exact
purpose of using Whittemore and knafl (2005) updated methodology framework with being
aware Cooper’s (1998) framework falls short by not addressing issues specific to integrative
review method as the challenges of combining diverse areas of data sources are not being
considered. Therefore, this framework will be modified to address issues specific to integrative
review method (Whittemore & Knalf, 2005). The updated framework served as foundation for
this integrative study. It ensured all necessary paths including the stages of data analysis. The
stages were chronologically followed for the basis of reaching project’s objective by preventing
all potential deviations, error, and bias in the process; allowing the project to be properly written
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and honestly reported in a manner that can be easily understood by readers and facilitating its
replication by healthcare professionals in clinical practices accurately.
SECTION FIVE: DATA ANALYSIS AND SYNTHESIS
Although integrative review allows different views of the problem question and its use
suggests in nursing science, its concept of allowing the combination of diverse methodologies
increases risk for lack of rigour, inaccuracy and bias. This concept is also problematic for data
collection process from primary sources. Whittemore and Knafl (2005), note methods of
analysis, synthesis, and conclusion are poorly formulated. This is a considerable issue, as data
extracted from primary articles of diverse methodologies generally consist of a large repertoire
of varied data. The sheer size and complexity of the data set sometimes makes the analysis
daunting, but a large data set may also yield richer and more useful information (Namey, 2007,
p. 137). Listing and defining variables was an inevitable step for seeking data but a challenging
process that can be eased through method of constant comparison. The application of the
constant comparison method used in broad array of qualitative designs that converts extracted
data into systematic categories, facilitating the distinction of patterns, themes, variations and
relationships (Glaser 1978; Miles & Huberman 1994; Patton 2002, as cited in Whittemore &
Knafl, 2005) was greatly beneficial to this review at this point. The method consists of data
reduction, data display, data comparison, conclusion drawing and verification in which extracted
data are compared item by item so that similar data are categorized and grouped together.
Subsequently these coded categories are compared which further the analysis and synthesis
process (Whittemore & Knafl, 2005).
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Data reduction
In this very initial phase is involved the determination of an overall classification system
for data management. As the relevant studies were collected, they were classified into subgroups
to facilitate data extraction and reduction. The initial subgroup classification of collected primary
sources were organized from the highest to the lowest level of evidence and analyzed
sequentially. The second subgroup, data reduction involved the process of extracting and coding
data from primary sources to simplify, abstract, focus and organize data into a manageable
framework (Whittemore and Knafl, 2005, p. 550). A predefined matrix divided into sub-sections
was developed for each primary source to keep extracted relevant data, presented on a simplified
form in a single page with contents similar to the primary sources. The sub-sections were made
of study details; author, study objective, design, level of evidence, interventions, results strengths
and limitations. This approach provides succinct organization of the literature which facilitates
the ability to systematically compare primary sources on specific issues, variables or sample
characteristics (Whittemore & Knafl, 2005, p. 550).
Data Display
Display of data collected in the initial stage is critical. Whittemore and Knafl (2005)
described data display as the next step in data analysis which involves converting the extracted
data from individual sources into a display that assembles the data from multiple primary sources
around particular variables or subgroups. At this phase in the process the coded extracted data
from matrices in the initial phase were displayed into one matrix setting the stage for
comparison. This is a strategy to summarize data characteristics individually and arranged in
ways that are highly comprehensible and meaningful as in the primary sources. These displays
strengthen the visualizations of patterns and relationships within and across primary data sources
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and serve as a starting point for interpretation (Knafl & Webster 1988; Sandelowski 1995 cited
in Whittemore and Knafl, 2005, p. 551).
Data Comparison
This phase of data comparison is the process where data that have been displayed in the
matrix on data display were examined to identify patterns, themes, or relationships. Variables or
themes identified as similar were placed near on a matrix and displayed in chronological order so
that relationships can be depicted between them to facilitate the comparison process. According
to Whittemore & Knafl (2005), creativity and critical analysis of data displays are key elements
in data comparison and the identification of important and accurate patterns and themes (p. 551).
This process of data visualization and comparison facilitates early interpreting efforts and highly
strengthen review end results (Whittemore & Knafl, 2005).
Conclusion drawing and Verification
This last phase of data analysis is conclusion drawing and verification which moves the
interpretive efforts from the description of patterns and relationships to higher level of abstracts,
subsuming the particulars into the general (Whittemore and Knafl 2005, p. 551). In this phase,
generalization from each subgroup became apparent, patterns and processes were isolated,
similarities and differences among included sources were identified. There took place a transition
from sub-groupings to a comprehensible summing or synthesis of important elements following
data analysis of each subgroup. This upheld the development of a new conceptualization of
primary sources, which involved all subgroups into a comprehensive representation of the
phenomenon of interest, completing the review process as per Whittemore and knafl (2005).
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Descriptive Results
For this integrative review, search of databases generated 1037 articles. Following the
process of inclusion and exclusion criteria, 20 articles identified as the most relevant to the
search objective focusing on finding intervention supporting the reduction of hospital
readmissions among COPD population were collected for this integrative study. Systematic
review and data analysis of those articles revealed diverse intervention methods were studied to
evaluate their level of effectiveness in reducing readmissions among COPD patients with excess
readmission rates. Comprehensive disease management interventions services varied. They
include services such as education, case management, discharge follow ups and many others.
The interventions were conducted by multidisciplinary team, general and specialist physicians,
nurses and pharmacist in clinics by telephone, community home visit, and inpatient.
Interventions concentrated on reviewing discharge medication reconciliation, addressing anxiety
issues, assessing financial difficulties related to buying medication, teaching correct inhaler use
via the teach-back method, self management education and initiation of action plan have largely
shown promising results in COPD readmissions reduction in addition to improve quality of life,
decrease length of stay, emergency visits, morbidity and mortality (Alshabanat et al., 2017,
Euceda et al., 2018; Health Quality Ontario, 2017; Hegelund et al., 2019; & Van Eeden, 2017 ).
Other researchers (Benzo et al., 2016; Johnson-Warrington et al., 2016; Ko et al., 2017;
McGurran et al., 2019; Ngyen et al., 2014; Plishka et al., 2019; & Vanhaecht et al., 2016) in their
studies such as individualized care plan or clinical pathway which include some service
components already mentioned above adding to physiotherapy or pulmonary rehabilitation;
pharmacy led comprehensive therapeutic interchange program (CTIP) used as a method of
pharmaceutical cost management and a way to standardize hospital therapy; health coaching with
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initiation of motivational interviewing, and moderate to vigorous physical activity interventions
echoed similar optimism findings.
Adamson et al (2016), in contrast to Ko and his colleagues combined comprehensive
individualized care with bundled care and their findings cannot be more different, concluding
comprehensive individualized care for subjects admitted to hospital for AECOPD did not reduce
30 and 90-day readmission rates but did reduce 90-day total mortality. Interestingly, it reduced
90-day readmission rate in females. On the other hand, Press et al. (2018) study has drawn mixed
results with combined interdisciplinary teams with bundled care in reducing readmission
although effective at improving other areas beneficial to COPD patients’ wellbeing. The
interdisciplinary teams with bundled care assessing impact of post hospital reduction
readmission program (HRRP), aimed at reducing readmission were uniformly successful at
improving quality of care provided and demonstrating improved process measures. However,
success at reducing readmissions and cost varied with interventions. Early home monitoring
interventions did not decrease rates of readmissions in COPD patients and evidence is lacking to
recommend specific intervention (Prieto-Centurion et al., 2014., Jurado-Gamez et al., 2012;
2013).
Of the interventions reviewed in the literature, 75% have shown to be highly effective in
correlation to the phenomenon of interest although time period among them varied with
intervention type; 7, 30, 60, 90, 180 day, or mixed in some cases. Others have raised some level
of doubts with 10% concluded they may have an impact on readmissions reduction, 5% have
shown varied results, and 5% have found it inadequate to recommend any specific intervention.
The remaining 5% dismissed all claim intervention has an impact on COPD readmission rates.
Some among those with promising results on COPD readmissions are as well effective in their
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secondary objectives in reducing all cause readmissions, length of stay (LOS), emergency (ER)
visits, mortality, morbidity, depression, improve quality of life (QOL) and health care costs
which believed to have close relationships with the issue of concern. Some offer potential
benefits in the management of other chronic diseases such as asthma, chronic heart failure
(CHF), diabetes, and pneumonia. These additional benefits were also varied with intervention
type.
Figure 2
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Note: This graph shows most of the studies are effective in reducing readmission rates and healthcare
related costs.
Synthesis

Careful review of data extracted from the primary sources in the process of data analysis
has revealed relevant information in relationship to the phenomenon of interest. It is shown
handful researchers are in agreement of the magnitude of COPD readmission rates on health and
healthcare expenditures and in no doubt should be addressed without delay by focusing on
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associated risk factors. As priority in their research, diverse intervention methods tested on
COPD patient population with excess readmissions have generated promising results. Their
detailed and comprehensive conclusions of their findings cover factors far beyond interventions’
effectiveness on reducing readmissions. Clinical evidence drawn from the literature has
overwhelmingly shown evidence-based interventions designed to reduce readmissions within the
COPD population are being largely effective.
Regardless of the patients’ age group, those with poorly managed COPD were likely to be
readmitted for COPD complications such as AECOPD. It is found admitted patients need
additional care besides hospital treatment that addresses issues far beyond COPD management.
The adoption of a healthcare plan that not only addresses the COPD condition was successful in
improving the overall quality of health. 75% of this review findings show patients who received
well tailored multidisciplinary transitional discharge care plan, comprehensive case management,
care pathway, pulmonary rehabilitation and health coaching among others either inpatient, by
home visits or telephonic have a significant decrease in their readmission rates. Those who did
not adopt the intervention program showed severe ailment and other COPD- related
complications.
Pharmaceutical intervention shows that the use of new drugs also played a significant role in
reducing COPD readmission rates. Those patients who received the new drugs responded
positively and got discharged quickly from the hospital. For instance, Albuterol, Ipratropium,
and Levalbuterol are among the short-acting bronchodilators. Additionally, the long-acting
bronchodilators include Brovana, Tiotropium, Salmeterol, and Aclidinium. These drugs help to
make breathing easier. They can be administered in the community for better disease
management.
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These designed interventions go far beyond reducing readmissions by improving other
chronic diseases such as asthma, chronic heart failure (CHF), diabetes, and pneumonia, as well
as mortality and morbidity rates, length of stay, emergency visits , and decrease care costs .
However, these findings varied with type of interventions and their duration. Intervention
programs are believed to be less costly compare to the price tag associated to readmissions.
Ethical Considerations
Integrative review is known as research of research. Ethics is considered as a critical and
an integral part of any research project but may require unique considerations depend on the
focus population. In the healthcare field researchers are obligated to adhere to ethical standards
to ensure data protection, privacy, confidentiality and human rights are respected as they hold
responsibilities to their profession, and clients. Therefore, it was a priority as the leader in charge
of this research project to thoroughly examine all included articles for ethical issues that may
have been involved with potential to affect this review end results meant to be implemented in
future clinical settings where humans will be involved. Strict standard measures were followed to
prevent potential bias that may occur by critically and systematically screened all included
articles for ethical concerns, clearly define the project study and use of adequate methods to
enhance review accuracy and transparency. Other ethical requirements for this study were met by
completing the 15 hour Collaborative Institutional Training Initiative (CITI). Request was
submitted to the Institutional Review Board (IRB) for project approval but was deemed
unnecessary as per the board for not involving human subject. As a result, inform consent
usually a key priority in research project involving human participants became irrelevant.
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TIMELINE
Complete a final project is standard academic requirement for graduation at a doctoral
level. This is a challenging task to take on and requires strict discipline in time management to
meet this expectation. An established timeline created based on the University’s DNP handbook
kept the project leader organized to timely complete the research study by graduation set date.
This was a teamwork effort, working collaboratively with the chair every step of way for
constructive criticism for corrections to be made as necessary and support from others as the
university librarian with the search strategy for studies selections for timely progress. Below is
an overview highlighting the process of the timeline development, its importance and contents
leading to the project timely completion.
The development of this timeline was based on the project stages as classified by Toronto
and Remington in their book titled “A step-by-step guide to oonduoting and integrative review.”
Initially, a rough draft of the timeline was drawn at the beginning of the first practicum course,
displayed a breakdown of the research project major sections and sub-sections with expected
time to be covered individually, along with set time for routine draft submission to the chair for
constructive criticism in order to stay on path. This established timeline was reviewed every 8
week term following a thorough examination of weekly class expectations and demands in
parallel to professional and personal lifestyles for modification to be made accordingly within it.
The timeline initiative taken as the only pathway for the project to be completed by the time of
graduation did not disappoint. It was helpful and was used as an effective guide in addition to
strong support from the project chair, hard work and determination leading to a smooth process
of project completion.
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SECTION SIX: DISCUSSION
Preliminary review findings for this research study highlighted the extent of health and
financial consequences associated with COPD disease. To date, millions of Americans are being
affected with billions of dollars spent yearly in direct care. This population is living a poor
quality of life while their providers in charge to help improve it are continuously failing them.
Appropriate care coordination is lacking leading to severe health complications resulting in
frequent hospital readmissions increasing their health risks, ER visit; increase mortality,
morbidity rates, and care costs. The billions of dollars spent for care are likely to increase as this
population is expected to grow in the future because of the aging population. These results lead
to a comprehensive systematic review which findings revealed interesting intervention strategies
to reduce COPD readmissions.
The COPD intervention methods tested although they were tailored differently, they were
used for one common goal of finding effective interventions supporting reduction of COPD
readmissions. The interventions managed to target known risk factors to readmissions by
integrating intervention plan services designed to encounter them to improve this population’s
health outcomes.
Evidence-based findings for this research study demonstrate intervention programs can
reduce readmission, especially those who deploy an interdisciplinary team approach, with
various care interventions that were successful at enhancing the quality of healthcare outcomes.
Several intervention programs had a varying success rate as depicted by different studies. The
implementation of a comprehensive intervention program for COPD patients in clinical practice
facilitates successful management of COPD disease from lifestyle changes to self-care
management, medications adherence , improve discharge care coordination for prompt post
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discharge follow ups with general and/or specialist physicians critical to prevent COPD related
complications and readmissions. Early discharge follow up or action based type intervention
facilitate patient access to much needed support they need to remain well and stable in their
respective community.
Implications for Practice/ Future Work
Recent literature findings have demonstrated readmission in COPD patients is serious
health threats and a societal burden considering its weight on healthcare expenditures. The
resulting health and financial consequences are enormous from poor quality of life, morbidity,
mortality, and in severe case scenario deaths. Those consequences are deeply concerning to
patients, their health providers and payers for measures to be initiated toward identifying
potential risk factors and effective intervention strategies to improve COPD quality care to
reduce readmission rates. The conclusion drawn from this integrative review in relation to the
research question has overwhelmingly shown potential benefits for future practice. The
implementation of a comprehensive intervention program for COPD patients will facilitate
successful management of COPD disease through lifestyle changes, self-care management
education, medications adherence, and prompt post discharge follow ups with general and/or
specialist physicians. Comprehensive intervention program for COPD patients, including
education, case management, and follow up were associated with significant reduction of
hospital readmission and length stay (Alshabanat et al, 2017., Benzo et al., 2016). A CCMP can
reduce readmissions through attention to social variables, optimization of in-hospital care,
improved coordination of pre- and post-discharge, a system to better identify problems after
discharge, and an office setup that accommodates same-day visits (Euceda et al., 2018, p. 185).
These interventions in turn will prevent all potential factors leading to readmissions, decrease
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morbidity, and mortality. Furthermore, a successful COPD management intervention program is
believed to decrease emergency visits, hospital length of stay, and improve quality of life.
Additionally, some offer potential benefits in the management of other chronic diseases such as
asthma, chronic heart failure (CHF), diabetes, and pneumonia. Chronic illnesses highly
contribute to the financial costs of healthcare with AECOPD makes for up to 70% of all related
COPD healthcare costs. The combined cost of direct COPD care and readmission is
overwhelming and deeply concerning with millions of Americans are already being affected by
the disease with the prevalence expected to rise.
An effective translation of this evidence-based finding in clinical practice will influence
this population health as well the cost of healthcare by reducing readmission rates. Those in
position of leadership have the potential to make this study finding part of their organization’s
standard policy for clinical care provided to be evidence-based to improve patients’ health
outcomes and health care costs. Because of these potential health and financial benefits, it is to
be promoted by developing new policies or updating existing ones locally, nationally and
internationally as an effective strategy to transform the delivery of healthcare and improve health
outcomes.
Despite review result is shown to be overwhelmingly promising, limitations within the
study are worth being highlighted for suggestions. With almost all included studies being strictly
limited to the highest level of evidence, relevant clinical researches may have been missed
influencing the end results. Interventions such as early home monitoring, comprehensive
individualized care, comprehensive care management program, and interdisciplinary teams with
bundled are either ineffective in reducing COPD readmissions, provide mixed results, possibly
effective or the evidence is somehow inadequate to recommend specific interventions to reduce
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readmissions although they still provide some other health benefits for this population. Further
research including articles with more diverse level of evidence, and larger samples should be
conducted for certainty.
Dissemination
Evidence-based practice is well known to improve care outcomes when successfully
translated into clinical practice. However, despite mounting of available evidence promoting its
benefits, healthcare providers have yet to make it part of their daily clinical care routine. This
review results will be disseminated appropriately using effective strategies to reach intended
goals. The reason behind the project and the target audience will be thoroughly evaluated to base
the dissemination process strategy for successful distribution of clinical findings. The evidencebased use and health outcome benefits will be effectively and rigorously promoted through
presentation of results to colleagues in clinical practice and other peers in the field to enhance
their routine practice and care outcomes. There are multiple strategies through which findings
from this review can be shared. Publication, particularly online is one of the most effective ways
considering these days technology is at the center of every healthcare organization as an effective
strategy for quality improvement. Different types of technology such as computers, iphones,
ipads must be readily available to all clinical staff to facilitate them instant and unlimited access
to vast clinical researches pertaining to improve clinical care practices. It can also be promoted
through presentation of abstract in different venues pertaining to influence policy, enhance
healthcare quality improvement, patient safety, and evidence base use in clinical practice. Other
ways include through presentation at local, national conferences and meetings of professional
associations, social media or on an organization's website, and through grassroots advocacy to
influence lawmakers and/or policy makers in their decisions. At this level, it is identified
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effective and well structured communication is imperative so that the message reaches the
intended audience. For that to occur, the project leader must do some work by identifying the
what, why, where, who, and how. These are key questions deserved to be answered for proper
and successful dissemination of this research finding. Through this dissemination strategy,
finding will likely be put to use by providers, enhance health outcomes, patients’ safety and
reduce healthcare utilization as reflected by readmissions.
A successful dissemination can be achieved collaboratively starting from the
implementation phase. It is a shared responsibility of all potential stakeholders which task should
be promoted among them. This is presumably done from the beginning by the project leader to
avoid potential resistance while convincing them to be an integrative part of the process to
achieve the intending goal and enhance health outcomes for readmissions reduction. The change
agent should use strong leadership in his or her role to educate the target audience of the
project’s objective, seeks to know their concerns to be addressed and get them actively involved
in the process. Being in a leadership position requires leaders to have standard skills to succeed
in their roles including having listening ears, ability to communicate clearly and effectively.
These skills, in addition to routine meetings for updates, questions, and feedbacks are necessary
to keep everyone in line with project’s goals for best outcomes to be achieved.
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Appendices
Literature matrix

Article

Purpose

Sample

Impact of
individualiz
ed care on
readmission
s after a
hospitalizat
ion for
acute
exacerbatio
n of COPD.

Examined
how
individuali
zed
comprehen
sive care
influences
readmissio
ns
following
an index
hospital
admission
for
AECOPD.

Impact of a
COPD
comprehens
ive case
managemen
t program
on hospital
length of
stay and
readmission

To
determine
the efficacy
of a
comprehen
sive case
manageme
nt program
(CCMP) in
reducing

Method

Major
Findings

Limitations

Gaps

Two innerLevel 2
city teaching retrospectiv
hospitals
e study.
control group
consisted of
271 patients
whose index
AECOPD
occurred the
year before
the
comprehensiv
e program,
and the
experimental
group
consisted of
191 patients
who received
the
comprehensiv
e care.

Comprehen
sive
individuali
zed care for
subjects
admitted to
hospital for
AECOPD
did not
reduce 30and 90-day
readmissio
n rates but
did reduce
90-day
total
mortality.
Interestingly, it
reduced
90-day
readmissio
n rate in
females.

The
population
low average
socioeconomic
status and
unusually
high rates of
SA and
mental
illness. The
results of
the study
may
therefore
have
reduced
generalizabi
lity. The
care
delivered to
each patient
was
purposely
unique

Not all
variables
could be
collected
for every
patient,
preventing
the
inclusion
of
parameter
s such as
FEV1,
body mass
index,
pack-years
of
smoking
history,
and
socioecon
omic
factors
into the
analysis.

Five large
hospitals in
Vancouver,
BC, Canada

A
comprehen
sive
disease
manageme
nt program
for COPD
patients,
including
education,

The lack of
medical
history and
pulmonary
function
data as an
assessment
of severity,
and the lack
of risk

There was
no
individual
consent of
the
patients.
Therefore,
issues on
confidentia
lity.

Level 2
retrospectiv
e study
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rates

length of
stay (LOS)
and risk of
hospital
admissions
and
readmissions in
patients
with COPD

Health
Coaching
and
Chronic
Obstructive
Pulmonary
Disease Rehospitalizat
ion. A
Randomize
d Study

To
determine
the effect
of
comprehen
sive health
coaching
on the rate
of COPD
readmissio
ns

Total of 215
patients
hospitalized
for a COPD
exacerbation
were
randomized a
t hospital
discharge to
receive either
(1)
motivational
interviewing–
based health
coaching
plus a written
action plan
for
exacerbations
(the use of
antibiotics
and oral
steroids) and
brief exercise
advice or(2)
usual care.
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Level 2
randomized
controlled
trial

case
manageme
nt, and
follow-up,
was
associated
with
significant
reduction
in hospital
admissions
and LOS

factor/expos
ure
information
(eg,
smoking
status) for
individuals

The study
is prone to
bias when
selecting
data
because it
depends on
the
identificati
on of the
patients by
the
multidiscip
linary case
manageme
nt teams.

-Health
Coaching
may
represent a
feasible
and
possibly
effective
interventio
n designed
to reduce
COPD
readmissio
ns

In this
study, we
found
significant
differences
in the rates
of COPD
hospitalizati
ons at1, 3,
and
6months
post
discharge.
The study
was
powered to
find a
difference in
the rate of
hospitalizati
on at12
months,
which was
not found.

COPDrelated
hospitaliza
tions at 1,
3, and 6
months
after
hospital
discharge
were
considered
, but not at
1 year
after
discharge.
The
results
may
suggest a
negative
study
result if
only
hospitaliza
tion at 12
months is
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considered
.

The effects
of a
comprehens
ive care
managemen
t program
CCMP on
readmission
rates after
acute
exacerbatio
n of COPD
at a
community
-based
academic
hospital.
Chronic
Obstructive
Pulmonary
Diseases

To address
readmissio
n issues as
part of an
overall
quality
improveme
nt program

Level 2
A COPD
retrospective
readmission
study
reduction
initiative was
implemented
in September
2014 at
Danbury
Hospital,a
community
teaching
hospital in
Connecticut.
272 patients
were included

Results
from the
hospital
and
previous
studies
have
suggested
that there
might be
benefit in a
COPD
CCMP

Few
limitations.
First, single
center
study,
selection
bias can be
a concern.
Second, the
small
sample size
in the
readmission
group might
have limited
our power
to show
statistical
significance

There
have
not been
well
accepted
manageme
nt
modalities
and
guidelines
that
address
psychosoc
ial risk
factors for
the
prevention
of COPD
readmissio
ns.

Effect of
early
follow-up
after
hospital
discharge
on
outcomes in
patients
with heart
failure or
chronic
obstructive
pulmonary
disease: A
systematic
review.

Evaluated
the clinical
effectivene
ss of early
follow-up,
within
either 7
days or 30
days after
hospital
discharge,
compared
with usual
care or a
different
time to
follow-up,

Level 1
10 eligible
systematic
studies: one
Review
randomized
controlled
trial, two
nonrandomiz
ed controlled
trials, and
seven
observational
studies. Four
studies were
specifically
on 7-day
follow-up and
30-day health
outcomes.

Based on
low- and
very lowquality
evidence,
follow-up
within 7
days and
within 30
days of
discharge
from
hospitalizat
ion for
heart
failure or
COPD

Included
studies were
limited to
RTCs and
cohort
studies.

Overall,
there is a
lack of
large,
methodolo
gically
robust
studies
specificall
y focusing
on the
effectiven
ess of 7day
follow-up
after
discharge

Patients
who were
readmitted
to the
hospital
within 30days of
discharge
had follow
ups options
either
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The impact
of a
personalize
d action
plan
delivered at
discharge to
patients
with COPD
on
readmission
s: A pilot
study.

in reducing
readmissio
ns,
emergency
department
visits, and
mortality in
patients
with heart
failure or
COPD.

The other six
studies were
on 30-day
follow-up and
more variable
time to health
outcomes.

This pilot
study
aimed to
test
whether a
personalize
d, stepwise
action plan
supported
with a short
instruction
provided at
or postdischarge
after an
acute
exacerbatio

Participants
were
recruited
between
August 2016
and forward
until 100
patients were
identified.
Last patient
was included
on 22
February
2017.
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compared
with usual
care or no
follow-up
were both
associated
with a
reduced
risk of allcause
readmissio
n,
emergency
department
visits, and
mortality.

Randomized
controlled
trial

Compared
to the
control
group, the
action plan
group
significantl
y reduced
the
incidence
of
readmissio
ns. The
action plan
group
showed a
trend

1) clinic

visits with
internal
medicine,
family
medicine, or
cardiology
physicians
who
typically
had had
previous
contact with
the patient,
or 2)
telephone
calls by
nurses or
pharmacists
who may
not have
been
familiar
with the
patient.
Performed a
small, twocentre study
with limited
power, and
screened
almost 400
patients to
recruit 100
patients, and
thus,
patients
represent a
selected
group.

in
improving
patient
outcomes.

The
absence of
a large
group of
patients
within the
study. This

hampers
external
validity,
so results
may not
be
reproduce
d in other
COPD
cohorts.
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n in
chronic
obstructive
pulmonary
disease
admission
as an
addition to
usual care
reduces
readmissio
ns and
symptom
burden,
including
anxiety and
depression
levels at 3month
follow-up.

Can a
supported
selfmanagemen
t program
for COPD
upon
hospital
discharge
reduce
readmission
s? A
randomized
controlled
trial.

To
investigate
if SPACE
for COPD
employed
upon
hospital
discharge
would
reduce
readmissio
n rates at 3
months,
compared
with usual
care.

towards a
significant
decrease in
HADSdepression,
but none in
HADSanxiety.

Seventy-eight
patients were
recruited
(n=39 to both
groups).Partic
ipants were
recruited
from
University
Hospitals
Coven try and
Warwickshire
and
University
Hospitals of
Leicester
NHS Trusts.

Level 2
randomized
controlled
trial

SPACE for
COPD did
not reduce
readmissio
n rates at 3
months
above that
of usual
care.
However,
encouragin
g results
were seen
in
secondary
outcomes
for those
receiving
the
interventio
n.

Limitations
to this study
include
recruitment
constraints.
Due to
available
resources,
there was
not
complete
coverage to
recruit
during peak
admission
periods on
both sites.
In addition,
some
inpatient
stays were

The
inclusion
criteria
were
limited to
patients
with
COPD
diagnosis
and grade
2 to 5
dyspnea.
The
follow-up
period
was short
3 months.
The
sample
size was
insufficien
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Home
intervention
and
predictor
variables
for rehospitalizat
ion in
chronic
obstructive
pulmonary
disease
exacerbatio
ns.

To
determine,
first of all,
whether
home
follow-up
of patients
by a nurse
and
telephone
support
with a
pulmonolo
gist could
reduce the
rate of readmittance
in the 4
weeks
following
hospital
discharge.
Secondly,
we aimed
to
determine
whether at
the time of
hospital
discharge it

During The
study period
between
October 2010
and
November
2011, a total
of 211
patients were
hospitalized
due to severe
COPD
exacerbation.
71 included,
35 controlled
group and 36
intervention
group
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Level 2
prospective
nonrandomized
controlled
study

Importantly
, SPACE
for COPD
appears to
be safe and
may help
prevent
readmissio
n with 30
days

so brief that
being able
to perform
all research
procedures
within a
busy, acute
clinical
setting was
difficult.

t, with 78
patients.
There was
no
mention
of whether
the
intentionto-treat
analysis
was done.

Early home
monitoring
did not
decrease
the
readmissio
n rate
during the
first month.
Older age
and high
PaCO2 are
factors that
identify the
group with
a high risk
for rehospitalizat
ion.

Some
limitations.
Among
these is the
impossibilit
y to
randomize
the patients
due to the
difficulties
entailed in
visiting
some
patients’
homes.
Nevertheles
s, we opted
for a quasiexperimenta
l assignation
as the
patients
were only
assigned
depending
on the
possibility
of making a
home visit.

The
researcher
s did not
analyze
the
conventio
nal care
provided
by
Primary
Care
teams due
to the
difficulty
to
determine
this care
reliably in
each of
the
patients of
the control
group.
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is possible
to
determine
clinical
variables
that could
help predict
readmittance.
Comprehen
sive care
programme
for patients
with
chronic
obstructive
pulmonary
disease: A
randomized
controlled
trial.

Assess
whether a
comprehen
sive care
programme
would
decrease
hospital
readmissio
ns and
length of
hospital
stay (LOS)
for patients
with COPD

180 patients
were
recruited (IG,
N=90; UG,
N=90.
Patients
discharged
from hospital
after an
episode of
AECOPD
were
randomized
to an
intervention
group (IG) or
usual care
group (UG).

Level 2
randomized
controlled
trial

Outcomes
after early
and delayed
rehabilitatio
n for
exacerbatio
n of chronic
obstructive

To
compare
the
outcomes
between
early and
delayed PR

Among all of
the patients
hospitalized
owing to
COPD
exacerbation
during the
study period

Level 2
retrospective
cohort study

A
comprehen
sive COPD
programme
can reduce
hospital
readmissio
ns for
COPD and
LOS, in
addition to
improving
symptoms
and quality
of life of
the patients

One major
limitation of
this study is
that it was a
single
tertiary
centre study
and
involved
patients
with severe
COPD who
had just
experienced
an episode
of
AECOPD.

There was
no
mention
of
blinding
of the
control
group.

In this
national
database
study, early
PR was
associated
with

Patients
who did not
receive PR
were
excluded.
This may be
limiting the

Retrieved
data did
not
contain
postdischarge
long-term

Sample of
180
patients
were
insufficien
t and
There was
no
generaliza
bility of
the data as
it used one
hospital
only,
Prince of
Wales
Hospital.
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pulmonary
disease: A
nationwide
retrospectiv
e cohort
study in
Japan.

for
exacerbatio
n of COPD,
using a
national
inpatient
database.
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(n = 45,899),
we excluded
those who did
not receive
rehabilitation,
those
with LOS
>180 days,
and those
who were
discharged
to a place
other than
home.
Finally, we
identified
12,572
including
8459 patients
with delayed
PR and 4113
with early PR
eligible
patients
during the
study period.
After
exclusion of
patients with
missing data,
there were

reduced
90-day
readmissio
n and
shortened
LOS in
patients
with
exacerbatio
n of
COPD.
.

generazabili
ty of the
study.
Because of
data
limitations,
they could
not analyze
the details
of the PR
program and
the Barthel
index, one
of the
secondary
outcomes,
may not be
the most
appropriate
measure to
evaluate the
effect of PR.

outcomes.
Therefore,
they
cannot
completel
y detect
postdischarge
readmissio
n and
deaths.

There are
several
limitations
to this
study,
which was
conducted at
a single
health care
system and
was

The
researcher
relied on
the use of
ICD-10
codes for
the
diagnosis
of COPD,
as
opposed

6955 patients

Impact of a
Comprehen
sive COPD
therapeutic
interchange
program on
30-day
readmission
rates in
hospitalized
patients.
P&T
(Lawrencev

Evaluate
the clinical
and
financial
impact of a
comprehen
sive
therapeutic
interchange
program
(CTIP) in

This study
was a multicenter,
electronic
chart review
of patients
with a
diagnosis of
COPD
admitted to
two hospitals.

Level 2
retrospectiv
e study

This study
demonstrat
es that the
use of
pharmacistled CTIP of
COPD
inhalers
does not
worsen
patient
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ille, N.J.),
44(4), 185191

hospitalize
d patients
with
COPD. The
primary
outcome
was a 30day
readmissio
n rate, with
the
following
secondary
outcomes:
30-day
mortality
and
pharmacyinhaled
medication
cost per
patient.

2,885
hospitalized
patients with
a diagnosis of
COPD were
included in
the analysis
(1,350 in the
intervention
group and
1,535 in the
control
group).

outcomes
and may
provide
pharmacy
cost
savings.
The cohort
managed
with a
CTIP was
statistically
associated
with a
lower 30day
readmissio
n rate and
lower
pharmacyinhaled
medication
costs
without
any
difference
in 30-day
mortality.

retrospectiv
e in nature.

to clinical
diagnosis.
An
additional
limitation
is that
patients’
discharge
medicatio
n lists
were not
evaluated
to see if
patients
were
returned
to their
home
inhaler.

Effect of an
integrated
care
programme
on rehospitalizat
ion of
patients
with
chronic
obstructive
pulmonary
disease.

To evaluate
the
effectivene
ss of an
integrated
care
programme
with two
component
s (patientcentered
education+
case
manageme
nt)
in
preventing

Data were
Level 2
retrieved both retrospectiv
from an
e study
administrativ
e
database in
the province
of Quebec
(Canada),
and from the
medical
records at two
hospitals in
Montreal.
One hundred
and eightynine (189)

An IC
programme
combining
self
manageme
nt
education
and casemanageme
nt can
decrease
rates of
COPDrelated
hospitalizat

There are
several
limitations
to this
study, in
addition to
its design.
Sampling
was from
inpatient
clinics, than
in the
general
population
of COPD

Selection
bias was
possible,
patients
randomize
d to the
interventio
n and UC
groups
were not
recruited
at the
same
hospital
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COPDrelated
hospitalizat
ions,
and
whether
this was
comparable
for men
and
women.

COPD
patients
were
randomly
selected from
registers at
these centers,
from 2004 to
2006.

To examine
whether or
not a
potentially
modifiable
factor such
as regular
physical
activity at
baseline
was
associated
with lower
risk of 30day
readmissio
n in
patients
with
chronic
obstructive
pulmonary
disease
(COPD).

The Sample
included a
total of 4,596
patients from
a large
integrated
health care
system with
14 medical
centers
located in
southern
California

A
To evaluate Wake Forest
comprehens AECOPD
Baptist
ive care
admissions Medical

Association
s between
physical
activity and
30-day
readmission
risk in
chronic
obstructive
pulmonary
disease.
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ions,
particularly
among
women.

patients;
limit the
generalizabi
lity of the
findings.

Level 2
retrospectiv
e study

Participatio
n in Any
level of
regular
moderate
to vigorous
physical
activity
captured as
part of
routine
clinical
care was
associated
with a
significantl
y lower
risk of allcause 30day
readmissio
n in a large
cohort of
pts with
COPD

There are
several
limitations
to this
study. First,
study was
relied on
administrati
ve and
clinical
records,
specifically,
use of the
EVS, which
is routinely
collected by
frontline
clinical staff
during all
outpatient.
Second,
physical
inactivity
could
merely be
another
marker of
disease
severity.

The
cohort
was drawn
from an
insured
population
within a
financially
aligned
and
integrated
health
system,
and
thus the
findings
may not
be
generaliza
ble
to patients
with
COPD
who are
uninsured
or have
fee-forservice
public
insurance.

Level 2
retrospectiv

A
comprehen
sive care

Intervention
was an
integrative

Unlike a
true
randomize
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plan that
reduces
readmission
s after acute
exacerbatio
ns of
COPD.

between
5/12/2014
to
6/28/2016.

Center
e study
(WFBMC)
initiated a
comprehensiv
e AECOPD
care plan on
May 12,
2014. A total
of 1274
AECOPD
index
admissions
were
identified
within the
study period
admissions
occurring
between May
12, 2014
through June
28, 2016,
with
inpatient/obse
rvation status
and length of
stay equal to
or greater
than one day
among
patients aged
40 years or
older.
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plan
includes 1)
transitions
of care, 2)
diagnosis
and
treatment
of COPD
and 3) its
common
comorbidities
as well as
4) hospice
and
palliative
services
that
reduces
readmissio
ns after
acute
exacerbatio
ns of
COPD.

care plan, so
they were
unable to
determine
the
magnitude
of specific
components
on
respective
outcomes.
Limiting
enrollment
to only
those with
prehospitalizati
on
spirometry
would
introduce its
own bias
based on
differences
in the
population
of patients
with prehospital
spirometry
and those
without,
thus
evaluating a
skewed
population.

d trial, the
propensity
weighting
method
used in
this study
can only
adjust for
difference
s between
the
treatment
groups of
which we
have
knowledg
e.
The
authors
chose a
large
number
of
independe
nt
variables
from a
diverse
group of
data
domains
(e.g.
demograp
hics,
severity of
illness,
comorbidi
ties, health
care
utilization,
test
results,
medicatio
ns, socioeconomic
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status, and
social
history) in
order to
decrease
the
likelihood
that an
important
unmeasure
d variable
would
confound
the results.
Level 1
The search
systematic
strategy
identified 497 review
potentially
relevant titles.
Of these, 13
studies were
included in
the review.

Effects of
clinical
pathways
for COPD
on patient,
professiona
l, and
systems
outcomes:
A
systematic
review.

The
primary
aim of the
review was
to address
the
following
question:
What are
the effects
of CPWs
for COPD
on patient-,
professiona
l-, and
systemslevel
outcomes?

Reducing
chronic

This review Insights about Level VII
aims to
the economic expert
describe

This
systematic
review
reveals
evidence to
suggest
that CPWs
for COPD
have the
potential to
reduce
complicatio
ns,
readmissio
ns, and
length of
stay
without
negatively
influencing
mortality
or quality
of life.

Quality of
evidence
was
generally
low. The
authors
therefore
acknowledg
e that results
should be
interpreted
with caution
and note the
need for
additional

The
searches
were rerun in
December
2017 and
therefore
do not end
in 2015 as
originally
suggested.

Interventio
ns,

The literature
is limited to
factors that

The 30day
readmissio

This study
was not
informativ
e. It did
not
investigate
resource
use, also
take into
account
cost of
initial and
maintenan
ce
implement
ation.
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obstructive
pulmonary
disease
hospital
readmission
s. an
official
american
thoracic
society
workshop
report.

best
practices
and models
for
addressing
and
reducing
AECOPD
readmissio
ns across
diverse
hospitals
and health
systems
informed
by critical
stakeholder
s.

Interventio To report
ns to reduce the results
of a
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impact of
COPD
readmissions
post HRRP
based on
papers
published
between
January 2016
and August
2017 that
provide
insight into
the economic
impact of
COPD
readmissions
in the United
States.

opinion.

particularly
interdiscipl
inary teams
with
bundled
care, aimed
at reducing
readmissio
n were
uniformly
successful
at
improving
quality of
care
provided
and
demonstrati
ng
improved
process
measures.
However,
success at
reducing
readmissio
ns and cost
savings
based on
these
interventio
ns varied
across the
studies.

lead to higher
readmission
risks in
patients.

n
metric
may not
be the
most
salient
measure;
the
timeframe
may need
to
be
adjusted
and
additional
metrics
needed to
show
whether
hospitalbased
interventio
ns
improve
COPD
care
and
impact
patientcentered
outcomes,
such as
mortality,
patient
satisfactio
n,
adherence,
selfefficacy,
symptom,
and
exercise
tolerance.

Multiple
electronic
databases

Level 1
Systematic

The
evidence

This
Systematic

This study
did not
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rehospitalizat
ions after
chronic
obstructive
pulmonary
disease
exacerbatio
ns. A
systematic
review.

systematic
review of
randomized
clinical
trials
evaluating
interventio
ns to
reduce the
rehospitalizat
ions
after COPD
exacerbatio
n

were
review
systematicall
y searched to
identify
relevant
studies
published
between
January 1966
and June. 2013.
Among 913
titles and
abstracts
screened, 5
studies (1,393
participants)
met eligibility
criteria.

Outpatient
Follow-up
Visit and
30-Day
Emergency
Department
Visit and
Readmissio
n in
Patients
Hospitalize
d for

We
examined
the effect
of early
follow-up
visit with
patient’s
primary
care
physician
(PCP) or
pulmonolo

62 746
admissions
(Medicare
beneficiaries
66 years or
older
hospitalized
for COPD)
was
considered
for study

Level 2
retrospectiv
e study.

base is
inadequate
to
recommend
specific
interventio
ns to
reduce rehospitalizat
ions in this
population
and does
not justify
penalizing
hospitals
for high
30-day rehospitalizat
ion rates
after
COPD
exacerbatio
ns.

review has
potential
limitations.
They may
have missed
identifying
some
effective
intervention
s because
we
restricted
their review
to
randomized
clinical
trials.
Another
potential
limitation
involves
availability
of data.

include
evidence
from other
study
designs.
Also, this
review did
not
include
studies
that
focused
exclusivel
y on
pharmacol
ogical
interventio
ns, and we
may have
missed
identifyin
g
pharmacol
ogical
agents
effective
in
reducing
rehospitaliza
tions.

Continuity
with
patient’s
PCP or
pulmonolo
gist after an
acute
hospitalizat
ion may
lower rates
of ER visits

This study
included
only
veterans
who did not
have a PCP.

Chronically
ill patients
were
assigned to
a PCP with
no prior
relationship
may not
translate
into
immediate
reduction
in
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Chronic
Obstructive
Pulmonary
Disease.

Effectivene
ss of case
managemen
t in the
prevention
of COPD
readmissions:
a pilot
study.

gist
following
acute
hospitalizat
ion on the
30-day risk
of an
emergency
department
(ER) visit
and
readmissio
n

analysis. Of
these
admissions
based on
COPD-DRG,
87.6% had a
COPDrelated

This pilot
study
investigates
the use of
case
manageme
nt to reduce
readmissions
due to
COPD.

This is 10
participants
pilot study
within the
NACL [5]
was
performed
between 2012
and 2014 in
the Dutch
MC
Zuiderzee
hospital
in Lelystad.
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hospitalizat
ions.

and
readmissio
n in
patients
with
COPD.

International
Classification
of Diseases,
Ninth
Revision(ICi
-9) code
(491.xx,
492.xx, and
496) listed as
the primary
diagnosis.
Asthma
(ICi-9 code
493.xx) was
listed as the
primary
diagnosis in
an
additional11.
2% of these
admissions.
Level 2 pilot This pilot
study.
study
shows that
the number
of COPD
hospital readmissions
decreased
significantl
y after the
introductio
n of a case
manager.
Moreover,

This pilot
study with
one case
manager
was
designed as
a proof of
concept and
included
only 10
participants.
The results
need to be
interpreted

Regressio
n to
the mean
was not
taken into
account.
Therefore,
future
studies
should
include a
control
group.
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Impact of a
care
pathway for
COPD on
adherence
to
guidelines
and hospital
readmission
: A cluster
randomized
trial.

The
primary
aim of this
study was
to evaluate
whether
implementa
tion of a
care
pathway
(CP) for
COPD
improves
the 6
months
readmissio
n rate.
Secondary
outcomes
were the 30
days
readmissio
n rate,
mortality,
length of
stay and
adherence
to
guidelines.

Initially, 65
hospitals
were eligible
for inclusion.
After
receiving the
detailed study
protocol, 22
hospitals
decided to
participate in
the study,
whereof 11
hospitals
(n=174
patients) were
randomized
to the
intervention
group and 11
hospitals
(n=168
patients) to
the control
group.
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Level 2
cluster
randomized
trial.

there was
an
improveme
nt in
patientreported
healthrelated
quality of
life.

with
caution.

The
implementa
tion of this
in-hospital
CP for
COPD
exacerbatio
n has no
impact on
the 6
months
readmissio
n rate, but
it
significantl
y reduces
the 30 days
readmissio
n rate.

A weakness
of the study
is that 43
hospitals
withdrew
after
randomizati
on, which
resulted in a
smaller
sample size
than initially
targeted.
Limited
statistical
analysis and
weak study
design, the
internal
validity of
results is
limited.

An
economic
evaluation
was not
included
to
evaluate
whether
CPs also
impact
efficiency
of care.
Finally, in
the
context of
the rising
prevalence
of COPD,
CPs did
not
include
transmural
manageme
nt and
communit
y-based
treatment
of COPD.
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